-
ChargePoint Technology appoints business development manager for EMEIA
Jul 31, 2018, 03:48 AM by Michael CroftNEWCASTLE UPON TYNE, UNITED KINGDOM - Jul 30, 2018 - Powder containment and aseptic transfer valve specialist, ChargePoint Technology has appointed Andrew McCreadie as their new business development manager for Europe, Middle East, India and Africa (EMEIA)Full story -
Quartzy, ACD/Labs, Eli Lilly, And More: News From July 2018
Jul 30, 2018, 14:00 PM by Michael CroftFull storyBio-IT World | July featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Quartzy, ACD/Labs, Eli Lilly, and more.
-
Marianne K. Henderson, Senior Advisor on Biobanking, Joins the Scientific Advisory Board of CloudLIMS
Jul 30, 2018, 06:39 AM by Michael CroftWILMINGTON, DE, US - Jul 30, 2018 - CloudLIMS, a Laboratory Information Management company specialized in offering data management solutions for biorepositories, today announced that MsFull story -
What AI Professionals Worry About As AI Clears The Hype Curve
Jul 26, 2018, 14:15 PM by Michael CroftFull storyBio-IT World | When it comes to a hype curve, AI is coasting along it. This spring, Bio-IT World surveyed 124 professionals from pharma, biotech, academia, and more about the biggest opportunities and concerns associated with AI.
-
Certara Experts Highlight Quantitative Systems Pharmacology’s Role in First-in-Human Clinical Trials
Jul 26, 2018, 08:25 AM by Michael CroftPRINCETON, NJ - Jul 26, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, announced today that Clinical Pharmacology & Therapeutics has published its Letter to the Editor describing the important role that quantitative systems pharmacology (QSP) can play in defining dosing criteria for first-in-human (FIH) clinical trials,1 together with the European Medicines Agencys (EMAs) responseFull story -
DOULIX launches new DNA assembly tool perfect for iGEM students
Jul 26, 2018, 06:36 AM by Michael CroftVENICE, ITALY - Jul 25, 2018 - DOULIX , the synthetic biology toolbox to design, analyse and synthesise biological systems, today announced the launch of its new DNA assembly tool, the MoCLO wizardFull story -
Equus Compute Solutions Introduces the WHITEBOX OPEN™ R2660 Servers
Jul 25, 2018, 16:05 PM by Michael CroftEDINA, MN, UNITED STATES - Jul 25, 2018 - Equus Compute Solutions announces the release of its WHITEBOX OPEN R2660 and R2660 NVME servers, part of the Equus portfolio of custom cost-optimized open-hardware server and storage platformsFull story -
Quartzy Joins with Bioline, Biotium, and MP Biomedicals to Create the Most Diverse Digital Catalog of Lab Supplies in the Nation
Jul 25, 2018, 14:28 PM by Michael CroftPALO ALTO, CA, US - Jul 24, 2018 - Quartzy, the only free online laboratory supply management and ordering platform, announced today three new authorized distributor agreements with Bioline, Biotium, and MP Biomedicals, enabling Quartzys user base of more than 13,000 laboratories to procure these suppliers sought after products through the Quartzy ShopFull story -
23andMe Gets $300 Million Boost From GlaxoSmithKline To Develop New Drugs
Jul 25, 2018, 12:34 PM by Michael CroftForbes | GlaxoSmithKline, a London-based drug giant is partnering with 23andMe, the San Francisco genetics startup, to develop new medicines. The companies will split costs and profits equally, and Glaxo will make a $300 million investment in 23andMe. The collaboration will last four years.Full story -
Looking Forward: How Data Science Shapes Future Work
Jul 25, 2018, 08:35 AM by Michael CroftFull storyBio-IT World | At the 2018 Bio-IT World Conference & Expo, we dedicated a plenary session to a panel discussion on data science. Wanting to offer the conversation to our community, we asked Gaurav Kaushik, Associate Director, Data Products & Strategy at Foundation Medicine for his definition of “data science.”
-
A-Alpha Bio Awarded NSF Grant to Streamline Cancer Drug Development with Genetically Engineered Yeast
Jul 24, 2018, 10:22 AM by Michael CroftSEATTLE, WA - Jul 24, 2018 - A-Alpha Bio (http://www.aalphabio.com) announces that it has been awarded a National Science Foundation Phase I Small Business Innovation Research (SBIR) grant for $225,000 to develop AlphaSeq: a cell-based platform that will accelerate cancer drug development by enabling high-throughput and quantitative characterization of protein-protein interactionsFull story -
Illumina Releases Open Source AI Software
Jul 24, 2018, 09:35 AM by Michael CroftFull storyBio-IT World Brief | Illumina announced the release of open source, novel artificial intelligence (AI) software that can distinguish between potential disease-causing mutations, and the millions of benign genetic variants in individuals.
-
The Pistoia Alliance Launches the 2018 President’s Startup Challenge
Jul 24, 2018, 04:57 AM by Michael Croft- Jul 24, 2018 - The Pistoia Alliance has announced today that entries for its 2018 Presidents Startup Challenge are now open, and will close on Monday, 3rd September 2018Full story -
Protein Dynamic Solutions appoints Selena Larkin as Chief Commercial Officer
Jul 23, 2018, 21:31 PM by Michael CroftWAKEFIELD, MA - Jul 24, 2018 - PDS, developer of breakthrough technology for biologics characterization, appoints Dr. Selena Larkin to leadership teamFull story -
MDI Biological Laboratory to Sponsor 'Live Longer, Live Better' Lecture Series
Jul 23, 2018, 14:50 PM by Michael CroftBAR HARBOR, ME, UNITED STATES - Jul 23, 2018 - How close is medicine to an anti-aging pill? Can anti-aging therapies delay the onset of age-related degenerative diseases? What lifestyle choices can individuals make to prolong healthy lifespan?These are some of the tantalizing questions that will be addressed in a lecture series for the public by leading scientists in the field of aging research entitled Live Longer, Live BetterFull story -
Eight New Mouse Models For Alzheimer’s Disease Available To Researchers
Jul 23, 2018, 14:20 PM by Michael CroftFull storyBio-IT World Brief | The MODEL-AD Center, an ambitious project to develop and distribute precise mouse models of late-onset Alzheimer’s disease (AD), has released eight new models carrying genetic mutations found in patients.
-
Human Longevity Blasts Craig Venter, Claiming He Was Fired, Then Stole Trade Secrets — Poaching Staffers For Rival Operation
Jul 23, 2018, 10:28 AM by Michael CroftEndpoints News | On Friday, Human Longevity filed suit against ex-CEO and executive chairman Craig Venter, claiming that Venter had stolen trade secrets, recruited staffers, and planned to set up a rival organization.Full story -
Qlucore Omics Explorer used in analyses of human protein arrays
Jul 23, 2018, 05:54 AM by Michael CroftLUND, SWEDEN - Jul 23, 2018 - Qlucore Omics Explorer used in analyses of human protein arrays Qlucore, a world leader in the development of bioinformatics software, is pleased to announce a licence contract with Cambridge Protein Arrays Ltd Cambridge Protein Arrays LtdFull story -
CD GENOMIC Reaches a New High in Simplifying Genome Sequencing Technique: 2b-RAD
Jul 23, 2018, 05:24 AM by Michael CroftNEW YORK, NY, UNITED STATES - Jul 23, 2018 - CD Genomic Company is able to provide the 2b-RAD technique, the upgraded RAD technique to simplify genome sequencing technique thereby achieving genome-wide high-throughput SNP genotypingFull story -
VA, IBM Extend Watson For Genomics Partnership
Jul 19, 2018, 11:10 AM by Michael CroftFull storyBio-IT World Brief | Today the US Department of Veterans Affairs and IBM Watson Health announced the extension of a public-private partnership to apply artificial intelligence to help interpret cancer data in the treatment of Veteran patients.